ChemoCenturyx (CCXI) Sees IPO Price of $14-$16/Share

ChemoCenturyx, Inc. (Nasdaq: CCXI), filed an amended registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering amount is 4 million common shares and ChemoCenturyx sees an IPO price of $14 - $16 per share. ChemoCenturyx plans to list on the Nasdaq Global Market under the ticker "CCXI."

The offering is being made through J.P. Morgan, Citigroup, and Cowen and Company.

ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• Royal Caribbean completes $1.25B senior unsecured notes offering
• Evolution Petroleum closes $16M Midland Basin royalty acquisition